| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.002 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.18 | 0.003 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.003 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.2 | 0.004 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.085 | 0.005 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.007 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.007 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.007 |